CADS is a reliable and valid instrument for measuring distress due to chemotherapy-induced alopecia among Korean breast cancer patients.
The four factors that emerged in this analysis are reflected in the four subdomains: physical, emotional, activity, and relationship.
These subdomains reflect the findings of the previous qualitative study that evaluated distress of breast cancer patients because of hair loss during chemotherapy.
The EFA and CFA confirmed the construct validity of the tool. Concurrent and discriminant validity were demonstrated by its varying degree of correlations with body image, overall QOL, and self-esteem.
* Development paper
Ann Oncol. 2014 Feb;25(2):346-51. doi: 10.1093/annonc/mdt476. Epub 2013 Dec 29.
Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients.
PMID: 24379161 DOI: 10.1093/annonc/mdt476
* Contacts
Juhee Cho: jcho@skku.edu